Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York

被引：94

作者：

Bratu, Simona

Brooks, Steven

Burney, Sibte

Kochar, Sandeep

Gupta, Jyoti

Landman, David

Quale, John

机构：

[1] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA

[2] Kingsbrook Jewish Med Ctr, Brooklyn, NY USA

[3] Brookdale Univ Med Ctr, Brooklyn, NY USA

来源：

CLINICAL INFECTIOUS DISEASES | 2007年 / 44卷 / 07期

关键词：

D O I：

10.1086/512370

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

A carbapenem- resistant isolate of Escherichia coli was identified that possessed a 23- kb plasmid encoding Klebsiella pneumoniae carbapenemase type 2 (KPC- 2). A subsequent surveillance study involving hospitals in Brooklyn, New York, revealed that, among 1417 E. coli isolates, 7 isolates (from 3 hospitals) possessed bla(KPC-2). E. coli possessing KPC-2 is emerging in our region, and improved methods for detection are urgently needed.

引用

收藏

页码：972 / 975

页数：4

相关论文

共 29 条

[1]

[Anonymous], [No title captured]

[2] Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City [J].

Bradford, PA ;

Bratu, S ;

Urban, C ;

Visalli, M ;

Mariano, N ;

Landman, D ;

Rahal, JJ ;

Brooks, S ;

Cebular, S ;

Quale, J .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (01) :55-60

[3] Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York [J].

Bratu, S ;

Landman, D ;

Alam, M ;

Tolentino, E ;

Quale, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) :776-778

[4] Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City -: A new threat to our antibiotic armamentarium [J].

Bratu, S ;

Landman, D ;

Haag, R ;

Recco, R ;

Eramo, A ;

Alam, M ;

Quale, J .

ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (12) :1430-1435

[5] Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York:: Epidemiology and recommendations for detection [J].

Bratu, S ;

Mooty, M ;

Nichani, S ;

Landman, D ;

Gullans, C ;

Pettinato, B ;

Karumudi, U ;

Tolaney, P ;

Quale, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) :3018-3020

[6] DIFFUSION OF MEROPENEM AND IMIPENEM THROUGH THE OUTER-MEMBRANE OF ESCHERICHIA-COLI-K-12 AND CORRELATION WITH THEIR ANTIBACTERIAL ACTIVITIES [J].

CORNAGLIA, G ;

GUAN, LM ;

FONTANA, R ;

SATTA, G .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (09) :1902-1908

[7] Escherichia coli:: Development of carbapenem resistance during therapy [J].

Hong, T ;

Moland, ES ;

Abdalhamid, B ;

Hanson, ND ;

Wang, J ;

Sloan, C ;

Fabian, D ;

Faraiallah, A ;

Levine, J ;

Thomson, KS .

CLINICAL INFECTIOUS DISEASES, 2005, 40 (10) :E84-E86

[8] Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp. [J].

Hossain, A ;

Ferraro, MJ ;

Pino, RM ;

Dew, RB ;

Moland, ES ;

Lockhart, TJ ;

Thomson, KS ;

Goering, RV ;

Hanson, ND .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (11) :4438-4440

[9] Screening for antibiotic resistant Gram-negative bacteria [J].

Iredell, Jonathan R. ;

Sintchenko, Vitali .

LANCET INFECTIOUS DISEASES, 2006, 6 (06) :316-317

[10] Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class a carbapenemase KPC-2 [J].

Miriagou, V ;

Tzouvelekis, LS ;

Rossiter, S ;

Tzelepi, E ;

Angulo, FJ ;

Whichard, JA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (04) :1297-1300